[Granulated potassium citrate in the prevention of calcium oxalate lithiasis].
Since the approval of potassium citrate for the treatment of urolithiasis, there are many patients in other countries who have benefited from this drug. This paper describes the biochemical changes and tolerance seen in fifteen patients treated for one month with granulated potassium citrate. Some significant changes are observed in serum potassium and creatinine, and in urinary pH, citrate and potassium. Tolerance was good. Our results confirm that potassium citrate is an effective, easy to use, and well tolerated drug for the prophylaxis of oxalocalcium lithiasis.
Servicio de Urología, Hospital Universitario de Valme, Sevilla.
P
P
Campoy Martínez
M
M
Arrabal Martín
R
R
Quintero Rodríguez
F J
FJ
Espinosa Olmedo
J
J
Castillo Gómez
M
M
García Pérez
D002129:Calcium Oxalate / Q000032:analysis; D002951:Citrates / Q000627:therapeutic use*; D019343:Citric Acid; D004304:Dosage Forms; D005260:Female; D006801:Humans; D008297:Male; D014545:Urinary Calculi / Q000737:chemistry / Q000517:prevention & control*
D002951:Citrates; D004304:Dosage Forms; D002129:Calcium Oxalate; D019343:Citric Acid
Citrato potásico granulado en la profilaxis de la litiasis oxalocálcica.